Skip to main content
Erschienen in: International Urology and Nephrology 2/2013

01.04.2013 | Nephrology – Case Report

Successful treatment of Nocardia pneumonia with cytomegalovirus retinitis coinfection in a renal transplant recipient

verfasst von: Mohan P. Patel, Vivek B. Kute, Manoj R. Gumber, Pankaj R. Shah, Himanshu V. Patel, K. L. Dhananjay, Siddharth H. Jain, Hargovind L. Trivedi, Aruna V. Vanikar

Erschienen in: International Urology and Nephrology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Nocardiosis is a rare opportunistic infection, especially seen in immunocompromised patients, including renal allograft recipients. Primary pulmonary infection is the most common clinical pattern and can easily result in disseminated Nocardia infection if treatment therapy is not adequate at the beginning. We report a case of pulmonary nocardiosis associated with cytomegalovirus retinitis in a renal transplant recipient, followed by chronic allograft dysfunction. Our patient was a 50-year-old male renal allograft recipient, with diabetes mellitus and hypertension, who was diagnosed with pneumonia and cytomegalovirus retinitis. High-resolution computed tomography scan of the thorax and bronchoscopy revealed nocardial pneumonia. The patient responded well to ceftriaxone and was later switched to oral minocycline. To our knowledge, this is the first report of a successful treatment of co-infection with Nocardia pneumonia and cytomegalovirus retinitis in a renal transplant patient, with early diagnosis and prompt treatment.
Literatur
1.
Zurück zum Zitat Yu X, Han F, Wu J et al (2011) Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases. Transpl Infect Dis 13:385–391PubMedCrossRef Yu X, Han F, Wu J et al (2011) Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases. Transpl Infect Dis 13:385–391PubMedCrossRef
2.
Zurück zum Zitat Corti ME, Villafane-Fioti MF (2003) Nocardiosis: a review. Int J Infect Dis 799:243–250CrossRef Corti ME, Villafane-Fioti MF (2003) Nocardiosis: a review. Int J Infect Dis 799:243–250CrossRef
3.
Zurück zum Zitat Wilson JP, Turner HR, Kirchner KA, Chapman SW (1989) Nocardial infections in renal transplant recipients. Medicine 68:38–57PubMedCrossRef Wilson JP, Turner HR, Kirchner KA, Chapman SW (1989) Nocardial infections in renal transplant recipients. Medicine 68:38–57PubMedCrossRef
4.
Zurück zum Zitat Flohr TR (2009) Nocardiosis in a renal transplant recipient following rituximab preconditioning. Ups J Med Sci 114:62–64PubMedCrossRef Flohr TR (2009) Nocardiosis in a renal transplant recipient following rituximab preconditioning. Ups J Med Sci 114:62–64PubMedCrossRef
5.
Zurück zum Zitat Vigil KJ, Pasumarthy A, Johnson LB, Sheppard T, El-Ghoroury M, del Busto R (2007) Nocardiosis in renal transplant patients role of current immunosuppressant agents. Infect Dis Clin Pract 15:171–173CrossRef Vigil KJ, Pasumarthy A, Johnson LB, Sheppard T, El-Ghoroury M, del Busto R (2007) Nocardiosis in renal transplant patients role of current immunosuppressant agents. Infect Dis Clin Pract 15:171–173CrossRef
6.
Zurück zum Zitat Kontoyiannis DP, Ruoff K, Hooper DC (1998) Nocardia bacteremia: report of 4 cases and review of the literature. Medicine 77:255–267PubMedCrossRef Kontoyiannis DP, Ruoff K, Hooper DC (1998) Nocardia bacteremia: report of 4 cases and review of the literature. Medicine 77:255–267PubMedCrossRef
7.
Zurück zum Zitat Hörl MP, Schmitz M, Ivens K, Grabensee B (2002) Opportunistic infections after renal transplantation. Curr Opin Urol 12:115–123PubMedCrossRef Hörl MP, Schmitz M, Ivens K, Grabensee B (2002) Opportunistic infections after renal transplantation. Curr Opin Urol 12:115–123PubMedCrossRef
8.
Zurück zum Zitat Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261–1265PubMedCrossRef Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261–1265PubMedCrossRef
9.
Zurück zum Zitat Beaman BL, Beaman L (1994) Nocardia species: host-parasite relationships. Clin Microbiol Rev 7:213–264PubMed Beaman BL, Beaman L (1994) Nocardia species: host-parasite relationships. Clin Microbiol Rev 7:213–264PubMed
10.
Zurück zum Zitat Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA (2007) Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 44:1307–1314PubMedCrossRef Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA (2007) Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 44:1307–1314PubMedCrossRef
11.
Zurück zum Zitat Lederman ER, Crum NF (2004) A case series and focused review of nocardiosis clinical and microbiologic aspects. Medicine (Baltimore) 83:300–313CrossRef Lederman ER, Crum NF (2004) A case series and focused review of nocardiosis clinical and microbiologic aspects. Medicine (Baltimore) 83:300–313CrossRef
12.
Zurück zum Zitat Arthurs SK, Eid AJ, Pedersen RA et al (2008) Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 46:840–846PubMedCrossRef Arthurs SK, Eid AJ, Pedersen RA et al (2008) Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 46:840–846PubMedCrossRef
13.
Zurück zum Zitat Namnyak S, Uddin M, Ahmod N (2011) Nocardia cyriacigeorgica bacteraemia presenting with cytomegalovirus disease and rapidly fatal pneumonia in a renal transplant patient: a case report. J Med Case Rep 5:228PubMedCrossRef Namnyak S, Uddin M, Ahmod N (2011) Nocardia cyriacigeorgica bacteraemia presenting with cytomegalovirus disease and rapidly fatal pneumonia in a renal transplant patient: a case report. J Med Case Rep 5:228PubMedCrossRef
14.
Zurück zum Zitat Daly AS, McGeer A, Lipton JH (2003) Systemic nocardiosis following allogeneic bone marrow transplantation. Transpl Infect Dis 5:16–20PubMedCrossRef Daly AS, McGeer A, Lipton JH (2003) Systemic nocardiosis following allogeneic bone marrow transplantation. Transpl Infect Dis 5:16–20PubMedCrossRef
15.
Zurück zum Zitat Garlando F, BodmerT LeeC, Zimmerli W, Pirovino M (1992) Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report. Clin Infect Dis 15:1039–1040PubMedCrossRef Garlando F, BodmerT LeeC, Zimmerli W, Pirovino M (1992) Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report. Clin Infect Dis 15:1039–1040PubMedCrossRef
16.
Zurück zum Zitat Lewis KE, Ebden P, Wooster SL, Rees J, Harrison GA (2003) Multi-system infection with Nocardia farcinica: therapy with linezolid and minocycline. J Infect 46:199–202PubMedCrossRef Lewis KE, Ebden P, Wooster SL, Rees J, Harrison GA (2003) Multi-system infection with Nocardia farcinica: therapy with linezolid and minocycline. J Infect 46:199–202PubMedCrossRef
17.
Zurück zum Zitat Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P (2009) Nocardiosis at the turn of the century. Medicine (Baltimore) 88:250–261CrossRef Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P (2009) Nocardiosis at the turn of the century. Medicine (Baltimore) 88:250–261CrossRef
18.
Zurück zum Zitat Yu CT, Chua JA (2001) Nocardiosis. Phil J Microbiol Infect Dis 30:56–61 Yu CT, Chua JA (2001) Nocardiosis. Phil J Microbiol Infect Dis 30:56–61
19.
Zurück zum Zitat Jodlowski TZ, Melnychuk I, Conry J (2007) Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 41:1694–1699PubMedCrossRef Jodlowski TZ, Melnychuk I, Conry J (2007) Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 41:1694–1699PubMedCrossRef
20.
Zurück zum Zitat Conville PS, Witebsky FG (2007) Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and other aerobic actinomycetes. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology, 9th edn. ASM Press, Washington, DC, pp 515–542 Conville PS, Witebsky FG (2007) Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and other aerobic actinomycetes. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology, 9th edn. ASM Press, Washington, DC, pp 515–542
Metadaten
Titel
Successful treatment of Nocardia pneumonia with cytomegalovirus retinitis coinfection in a renal transplant recipient
verfasst von
Mohan P. Patel
Vivek B. Kute
Manoj R. Gumber
Pankaj R. Shah
Himanshu V. Patel
K. L. Dhananjay
Siddharth H. Jain
Hargovind L. Trivedi
Aruna V. Vanikar
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0113-9

Weitere Artikel der Ausgabe 2/2013

International Urology and Nephrology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.